99% Savings - Buy Just @1 Rs X
Wosulin 50/50 Solution for Injection 100 IU/ml is a prescription medicine that is available as a Injection. Primarily, it is used for the treatment of Diabetes Type 1, Diabetes Type 1. Secondary and off-label uses of Wosulin 50/50 Solution for Injection 100 IU/ml have also been mentioned below.
The correct dosage of Wosulin 50/50 Solution for Injection 100 IU/ml depends on the patient's age, gender, and medical history. The condition it has been prescribed for, and the route of administration also determine the right dosage. Detailed information has been provided in the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Wosulin 50/50 Solution for Injection 100 IU/ml as well, which are listed below. Normally, these side effects of Wosulin 50/50 Solution for Injection 100 IU/ml are not long lasting and go away when the treatment is finished. However, if these continue for a longer time, consult your doctor right away.
In addition, Wosulin 50/50 Solution for Injection 100 IU/ml's effect is Safe during pregnancy and Unknown for lactating mothers. In addition, Wosulin 50/50 Solution for Injection 100 IU/ml's effects on the liver, heart and kidney are discussed below in the Wosulin 50/50 Solution for Injection 100 IU/ml related warnings section.
Some other conditions that can be affected by Wosulin 50/50 Solution for Injection 100 IU/ml are listed in the contraindications section below.
Besides this, Wosulin 50/50 Solution for Injection 100 IU/ml may also have severe interaction with some medicines. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Wosulin 50/50 Solution for Injection 100 IU/ml is considered safe while driving, and is addictive.
Wosulin 50/50 Solution for Injection 100 IU/ml is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Wosulin 50/50 Solution for Injection 100 IU/ml safe for pregnant women?
Wosulin is safe to take during pregnancy.
Is the use of Wosulin 50/50 Solution for Injection 100 IU/ml safe during breastfeeding?
There is no research available on the side effects of Wosulin in breastfeeding women. Therefore, its impact is unknown.
What is the effect of Wosulin 50/50 Solution for Injection 100 IU/ml on the Kidneys?
Wosulin rarely affects the kidneys.
What is the effect of Wosulin 50/50 Solution for Injection 100 IU/ml on the Liver?
Wosulin is rarely harmful for the liver.
What is the effect of Wosulin 50/50 Solution for Injection 100 IU/ml on the Heart?
Wosulin may have mild side effects on the heart. Most people will never see any effect on the heart.
If you are suffering from any of the following diseases, you should not take Wosulin 50/50 Solution for Injection 100 IU/ml unless your doctor advises you to do so -
Is this Wosulin 50/50 Solution for Injection 100 IU/ml habit forming or addictive?
Forming a habit of Wosulin 50/50 Solution for Injection 100 IU/ml has not been reported.
Interaction between Food and Wosulin 50/50 Solution for Injection 100 IU/ml
Due to a lack of research, nothing can be said about the consequences of taking Wosulin 50/50 Solution for Injection 100 IU/ml together with food.
Interaction between Alcohol and Wosulin 50/50 Solution for Injection 100 IU/ml
Drinking alcohol while taking Wosulin 50/50 Solution for Injection 100 IU/ml may lead to slight side effects. If you experience any side effects, contact your doctor.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Novolin® N (Human Insulin Isophane)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Humulin® N (Human Insulin Isophane)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 693-695
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 265
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Humulin® R (regular insulin human)